Atrás
Rango del Día
$13.86
$14.27
Rango de 52 Semanas
$12.12
$35.34
Volumen
659,972
Promedio 50D / 200D
$13.73
/
$21.21
Cierre Anterior
$14.06
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -7.4 | 0.4 |
| P/B | 0.9 | 2.9 |
| ROE % | -11.5 | 3.7 |
| Net Margin % | -1136.3 | 3.8 |
| Rev Growth 5Y % | 28.8 | 10.0 |
| D/E | 0.0 | 0.2 |
Puntos Clave
Revenue grew 28.77% annually over 5 years — strong growth
Debt/Equity of 0.02 — conservative balance sheet
Negative free cash flow of -83.28M
Revenue growth is decelerating — 1Y growth trails 5Y average by 34.32%
Crecimiento
Revenue Growth (5Y)
28.77%
Revenue (1Y)-5.55%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-11.48%
ROIC-12.08%
Net Margin-1136.25%
Op. Margin-1576.67%
Seguridad
Debt / Equity
0.02
Current Ratio39.04
Interest Coverage0.00
Valoración
P/E Ratio
-7.44
P/B Ratio0.88
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -5.55% | Revenue Growth (3Y) | 11.23% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 28.77% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 10.00M | Net Income (TTM) | -113.63M |
| ROE | -11.48% | ROA | -11.34% |
| Gross Margin | 79.71% | Operating Margin | -1576.67% |
| Net Margin | -1136.25% | Free Cash Flow (TTM) | -83.28M |
| ROIC | -12.08% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.02 | Current Ratio | 39.04 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -7.44 | P/B Ratio | 0.88 |
| P/S Ratio | 84.56 | PEG Ratio | -0.18 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 845.56M | Enterprise Value | 815.37M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 10.00M | 10.59M | 8.08M | 8.61M | 3.64M |
| Net Income | -113.63M | -68.99M | -58.29M | -63.06M | -32.67M |
| EPS (Diluted) | -1.83 | -1.28 | -1.32 | -1.52 | -0.79 |
| Gross Profit | 7.97M | 8.53M | 6.13M | 7.77M | 3.64M |
| Operating Income | -157.67M | -98.85M | -72.98M | -67.09M | -32.93M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.00B | 1.06B | 380.41M | 364.01M | 379.82M |
| Total Liabilities | 44.74M | 38.74M | 36.06M | 43.27M | 13.50M |
| Shareholders' Equity | 956.82M | 1.02B | 344.35M | 320.74M | 366.33M |
| Total Debt | 22.14M | 23.03M | 24.54M | 25.31M | 194,000.0 |
| Cash & Equivalents | 52.33M | 430.61M | 19.21M | 51.43M | 35.58M |
| Current Assets | 975.89M | 1.03B | 349.24M | 332.44M | 377.02M |
| Current Liabilities | 25.00M | 17.46M | 13.03M | 16.51M | 12.80M |